Inspection Record

Bausch Health Companies Inc. — Health Canada Inspection Findings

Health CanadaInspected 2022-07-11 11 findingsEquipment and facilityComputer system validationOther quality systemValidation and qualificationDeviation, CAPA, and investigationStability and storage

View the regulator's official source The source document is always the basis for judgement.

Findings

1Equipment and facility

Evaluation of production processes, equipment, and/or materials was inadequate.

2Computer system validation

The preventative maintenance and repair of the equipment was inadequate. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

3Other quality system

The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

4Other quality system

The controls were inadequate for creating, modifying, reviewing, storing, and/or retrieving records. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

5Validation and qualification

The qualification and/or verification of utilities and/or support systems was inadequate.

6Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

7Deviation, CAPA, and investigation

The quality control department did not undertake all of the required activities. Investigations into deviations, reports, and/or follow-up actions were inadequate.

8Deviation, CAPA, and investigation

Investigations into deviations, reports, and/or follow-up actions were inadequate.

9Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. The receipt, preparation, and/or handling of reagents and culture media was inadequate.

10Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

11Equipment and facility

Changes to production processes, systems, equipment, materials, and/or suppliers were not validated before they were implemented.

About this record

Extracted automatically from the document of the Health Canada inspection on 2022-07-11. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Bausch Health Companies Inc. findings history — including this company's other documents Health Canada documents, 2022 Go to Findings search